AI brief of an SEC Form 8-K · Carpenter Technology (CRS)

Carpenter Technology closes $700 million notes sale, amends $500 million credit facility

Neutral Impact 3 of 5 financing Written later

Carpenter Technology closed a $700.0 million offering of 5.625% senior notes due 2034 and amended its credit facility, raising revolving commitments from $350 million of secured commitments to $500 million of unsecured commitments. The company plans to use the note proceeds and cash on hand to redeem in full its 6.375% notes due 2028 and 7.625% notes due 2030. The filing describes a refinancing of existing debt and does not report earnings or guidance.

Key points

  • $700.0 million of 5.625% senior notes due March 1, 2034 closed November 20, 2025, with semiannual interest starting March 1, 2026.
  • Proceeds, with cash on hand, will redeem in full the 6.375% senior notes due 2028 and the 7.625% senior notes due 2030.
  • Revolving commitments rise from $350 million secured to $500 million unsecured, with an uncommitted accordion of up to $650 million and maturity extended to 2030.
  • Notes can be redeemed before March 1, 2029 with a make-whole premium; certain change of control events require an offer to purchase at 101% of principal.

The filing

CompanyCarpenter Technology (CRS)
Form8-K, current report
Filed with the SECNov 20, 2025, 4:27 PM ET
Accession number0001104659-25-114628

Items reported: 1.01 Material Definitive Agreement2.03 New Direct Financial Obligation7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 20, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.